Blaricum

Researchers are evaluating the safety and effectiveness of the Supraflex Family sirolimus-eluting coronary stent system in patients with coronary artery disease. This study focuses on a 'real-world' population requiring stent implantation, aiming to understand the performance of this new generation biodegradable polymer stent that uses a cobalt-chromium platform for better flexibility and deliverability compared to earlier stainless steel models. The study involves patients who receive at least one Supraflex Family sirolimus-eluting stent as part of their planned clinical care. The stent's design includes a biodegradable polymer coating on a cobalt-chromium platform, intended to improve long-term safety and ease of use during procedures. Participants will be monitored to measure outcomes such as Target Lesion Failure over 12 months. The study includes follow-up visits to assess participant health and stent performance, with data collected on safety and efficacy. The total duration of monitoring is at least 12 months after stent implantation to evaluate the long-term results.